BioMarin Pharmaceutical
BMRN
#1978
Rank
A$14.62 B
Marketcap
A$75.66
Share price
-0.86%
Change (1 day)
-21.69%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): A$0.75 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$3.22 Billion. a decrease over its 2024 earnings that were of A$0.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 A$0.67 B-10.94%
2024 A$0.75 B187.31%
2023 A$0.26 B26.07%
2022 A$0.20 B-298.51%
2021 -A$0.11 Billion78.04%
2020 -A$59.14 Million-55.36%
2019 -A$0.14 Billion-33.56%
2018 -A$0.2 Billion297.78%
2017 -A$50.13 Million-95.68%
2016 -A$1.17 Billion437.12%
2015 -A$0.22 Billion23.91%
2014 -A$0.18 Billion-29.25%
2013 -A$0.25 Billion49.23%
2012 -A$0.17 Billion171.11%
2011 -A$60.96 Million103.01%
2010 -A$30.03 Million-3903.54%
2009 A$0.78 M-98.31%
2008 A$46.7 M-189.7%
2007 -A$52.07 Million51.02%
2006 -A$34.48 Million-61.58%
2005 -A$89.73 Million-56.59%
2004 -A$0.21 Billion95.13%
2003 -A$0.11 Billion12.09%
2002 -A$94.5 Million73.19%
2001 -A$54.56 Million18.32%
2000 -A$46.12 Million19.65%
1999 -A$38.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$10.75 B 1,495.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.72 Billion-205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.16 Billion-122.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$38.35 Million-105.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.26 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$0.39 B-41.24%๐Ÿ‡บ๐Ÿ‡ธ USA